Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Bioasis Technologies Inc.
V.BTI
Alternate Symbol(s):
BIOAF
Healthcare
Biotechnology
Bioasis Technologies Inc. is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and the xB3™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need. The in-house development programs are designed to...
develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
TSXV:BTI - Post Discussion
Bioasis Technologies Inc.
> Zacks update and target price
New Post
View:
Discussion
List
(92)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Jul 28, 2022 6:00pm
Zacks update and target price
Zacks Small Cap Research - BIOAF: FY 2022 Results and Valuation Update
(13)
•••
narmac
X
View Profile
View Bullboard History
Comment by
narmac
on Jul 28, 2022 8:33pm
MorningStar Rating. Valuation as of 27 Jul 2022 Fair ValueQoant 0.30 UncertaintyQoant: Extreme Last Close 0.13 BTI is Under Valued at a 59% discount.
(92)
•••
prophetoffactz
X
View Profile
View Bullboard History
Comment by
prophetoffactz
on Jul 28, 2022 9:31pm
"The product of our valuation work generates a target price of $0.70 per share...Our model forecasts development of GBS and will layer on valuations for the other two programs when launched." "Since our previous valuation update, Bioasis has put the xB3-001 program on hold and allocated resources to other active programs including the newly acquired CRES101. We remove the valuation
...more
(92)
•••
prophetoffactz
X
View Profile
View Bullboard History
Comment by
prophetoffactz
on Jul 29, 2022 5:36am
@carlquintanilla FUNDSTRAT: “.. disinflation tailwinds strengthening .. we think this is turning out to the be an August 1982 moment,” when stocks
...more
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
High-grade gold potential in the world’s best mining jurisdiction
Uranium Explorer to Commence Drill Program at Clearwater West Project in Saskatchewan